AOTS yields 9.52% · PFE yields 6.20%● Live data
📍 PFE pulled ahead of the other in Year 10
Combined, AOTS + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AOTS + PFE for your $10,000?
AOTS tracks an index of companies classified as software-driven enterprises, whose core business relies on software platforms and generates at least 20% of revenue from software-driven activities (cloud infrastructure, enterprise software, development tools, analytics/AI, middleware, industry solutions). Companies must have a positive Earnings to Price ratio to qualify. Selection is based on the average rank of a factor score (cost of goods sold/revenue, earnings/price, return on invested capital) and market cap, with the top 50 ranked firms and a 10-company buffer for incumbents. Weighting favors companies with over 50% software revenue, while those below are capped at 20%. Weights are float-adjusted, max 7.5%, min 0.5%, with over-5% weights keeping below 45% in total. The index is reconstituted and rebalanced on the third Friday of March, June, September, and December.
Full AOTS Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.